Evan G. Dick - 15 Feb 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Reporting relationship: Former Section 16 officer
Issuer ticker: CNTX
Reported as of: 15 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Feb 2022, 15:56:48 UTC
Prior SEC filing: 17 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Alex Levit, Attorney-in-Fact

Key filing fact

Evan G. Dick filed Form 4 for Context Therapeutics Inc. (CNTX) on 17 Feb 2022.

Key facts

This page summarizes Evan G. Dick's Form 4 filing for Context Therapeutics Inc. (CNTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Feb 2022, 15:56.

Change

Previous filing in this sequence was filed on 17 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +29,223
Change %
Price: $0.000000
Shares after: 29,223
Date: 15 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0
Exercise price: $2.05
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Evan G. Dick is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The stock option vests in equal monthly installments with 1/13th vesting on the last day of the calendar month in which the grant occurs and 1/13th on the last day of each subsequent month until fully vested on February 28, 2023. Additionally, 29,225 previously granted but unvested restricted stock units were cancelled as of December 30, 2021.